DAGM: a novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations

Saved in:
Bibliographic Details
Published inbioRxiv (Cold Spring Harbor Laboratory)
Format Paper
LanguageEnglish
Online AccessGet full text
DOI10.1101/2021.01.05.21249253

Cover

More Information
DOI:10.1101/2021.01.05.21249253